Novo Nordisk A/S Common Stock (NY:NVO)

37.32 UNCHANGED

Delayed Quote Updated: 7:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Novo Nordisk A/S Common Stock

< Previous 1 2

...

23 24 25 26 27 28 29 30 31

...

99 100 Next >

FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Novo Nordisk

September 30, 2025

From Faruqi & Faruqi, LLP

Via Business Wire

Trump's Plan To Lower U.S. Drug Prices Faces Big Test ↗

September 30, 2025

But Trump might get less than he bargained for as drugmakers focus on prices abroad, rather than stateside efforts.

Via Investor's Business Daily

Topics Government

Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Novo Nordisk A/S (NVO) Shareholders

September 30, 2025

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Fraud Lawsuit

LifeMD Offers Novo Nordisk’s Ozempic For $499 A Month To Eligible Patients ↗

September 30, 2025

Via Stocktwits

Why Wegovy Maker Novo Nordisk’s Stock Is Sliding 3% Premarket Today ↗

September 29, 2025

Via Stocktwits

Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Novo Nordisk A/S (NVO) Shareholders

September 30, 2025

Via TheNewswire.com

Topics Fraud Lawsuit

Why Is Novo Nordisk Stock Down in 2025, and Is It a Buying Opportunity? ↗

September 30, 2025

Political pressure on Big Pharma is one reason why the industry is underperforming in 2025.

Via The Motley Fool

These 2 Top Dividend Stocks Are Finally Rebounding, and There Might Be More Upside Ahead ↗

September 30, 2025

It's hard to keep these longtime winners down for too long.

Via The Motley Fool

Topics Artificial Intelligence Government World Trade

Why Novo Nordisk Stock Slumped on Monday ↗

September 29, 2025

A pundit tracking the company cited several reasons why investors should sell out of it.

Via The Motley Fool

Topics World Trade

Deadline Soon: Novo Nordisk A/S (NVO) Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit

September 29, 2025

From The Law Offices of Frank R. Cruz

Via Business Wire

NOVO URGENT DEADLINE ALERT: Bragar Eagel & Squire, P.C. Urges Novo Nordisk Investors to Contact the Firm Before September 30th

September 29, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

Contact Levi & Korsinsky by September 30, 2025 Deadline to Join Class Action Against Novo Nordisk A/S (NVO)

September 29, 2025

Via TheNewswire.com

Topics Fraud Lawsuit

Contact Levi & Korsinsky by September 30, 2025 Deadline to Join Class Action Against Novo Nordisk A/S (NVO)

September 29, 2025

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Fraud Lawsuit

Inventiva, MoonLake Immunotherapeutics And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗

September 29, 2025

U.S. stock futures were higher this morning, with the Dow futures gaining more than 100 points on Monday. Shares of Inventiva ADR (NASDAQ: IVA) fell sharply in today's pre-market trading following H1...

Via Benzinga

Topics Stocks

3 Magnificent Stocks Under $100 to Buy Right Now ↗

September 27, 2025

You won't need a huge amount of cash to invest in these great pharma stocks.

Via The Motley Fool

Investors Who Lost Money on Novo Nordisk A/S (NVO) Should Contact Levi & Korsinsky About Pending Class Action - NVO

September 26, 2025

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Fraud Lawsuit

Global Markets Brace for Impact as New U.S. Tariffs Escalate Trade Tensions Amidst Geopolitical Volatility

September 26, 2025

September 26, 2025 – Global financial markets are once again in the throes of uncertainty as the United States unveils a fresh wave of substantial trade tariffs, set to take effect on October 1, 2025....

Via MarketMinute

Topics Artificial Intelligence Economy Emissions

Investors Who Lost Money on Novo Nordisk A/S (NVO) Should Contact Levi & Korsinsky About Pending Class Action - NVO

September 26, 2025

Via TheNewswire.com

Topics Fraud Lawsuit

Novo Nordisk A/S Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – NVO

September 26, 2025

From DJS Law Group

Via Business Wire

Consumers Splurge, Intel, GlobalFoundries, Lilly, Paccar, American Woodmark Benefit From New Tariffs ↗

September 26, 2025

To gain an edge, this is what you need to know today.

Via Benzinga

NOVO DEADLINE ALERT: Bragar Eagel & Squire, P.C. Urges Novo Nordisk Investors to Contact the Firm Before September 30th

September 26, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

Trump's 100% Pharmaceutical Tariff: The $270 Billion Manufacturing War That Could Reshape Your Medicine Cabinet ↗

September 26, 2025

Trump’s sweeping 100% pharmaceutical tariff starting October 1 triggers massive $270 billion industry investment surge, creating clear stock market winners like Eli Lilly while foreign-de

Via Benzinga

Topics Government World Trade

Eli Lilly's GLP-1 Pill Just Beat Out Novo Nordisk's in a Test. Here's 1 Thing Investors Need to Know. ↗

September 26, 2025

Recent data from a head-to-head trial was positive for Eli Lilly, but it's not the whole story.

Via The Motley Fool

3 Absurdly Cheap Stocks You Can Buy for Less than $100 Right Now ↗

September 26, 2025

These stocks come with some uncertainty, but they have strong fundamentals and trade at low earnings multiples.

Via The Motley Fool

Topics World Trade

Trump Shocks Pharma With 100% Tariff On Imported Drugs Unless Companies Build In America ↗

September 25, 2025

Via Stocktwits

Topics Government

Faruqi & Faruqi Reminds Novo Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 30, 2025 - NVO

September 25, 2025

From Faruqi & Faruqi LLP

Via GlobeNewswire

Lost Money on Novo Nordisk A/S (NVO)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky

September 25, 2025

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Fraud Lawsuit

Lost Money on Novo Nordisk A/S (NVO)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky

September 25, 2025

Via TheNewswire.com

Topics Fraud Lawsuit

Does This Acquisition Make Pfizer Stock a Great Buy? ↗

September 25, 2025

There's an opportunity to get in on the weight-loss drug craze at a reasonable price.

Via The Motley Fool

Topics Death Intellectual Property

DEADLINE NEXT WEEK: Berger Montague Advises Novo Nordisk A/S (NYSE: NVO) Investors to Contact the Firm Before September 30, 2025

September 25, 2025

From Berger Montague

Via GlobeNewswire

< Previous 1 2

...

23 24 25 26 27 28 29 30 31

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.